GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7MIX | P05484 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIX | P54284 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIX | P54289 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIT | Q63664 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
7MIT | Q63563 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
7MGW | P31645 | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in NaCl in occluded conformation | |
7MGW | 7MGW | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in NaCl in occluded conformation | |
7MGD | P02866 | Concanavalin A bound to a DNA glycoconjugate, T(Man-T)TT | |
7MGC | P02866 | Concanavalin A bound to a DNA glycoconjugate, G(Man-T)AC | |
7MGB | P02866 | Concanavalin A bound to a DNA glycoconjugate, A(Man-T)AT | |
7MGA | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AAATTT | |
7MG9 | P02866 | Concanavalin A bound to DNA glycoconjugates, Man-TTTT and Man-AAAA | |
7MG8 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-CGCG | |
7MG7 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-GTAC | |
7MG6 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AGCT | |
7MG5 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-ATAT | |
7MFH | Q9R1E6 | Crystal structure of BIO-32546 bound mouse Autotaxin | |
7MFG | Q6WG00 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
7MFG | Q289M7 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
7MFG | 7MFG | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
7MF1 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
7MF1 | 7MF1 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
7MEQ | O15393 | Crystal structure of human TMPRSS2 in complex with Nafamostat | |
7MEP | 7MEP | BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R | |
7MEM | C3W5S1 | CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA | |
7MEM | 7MEM | CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA | |
7ME5 | Q7JQT0 | Structure of the extracellular WNT-binding module in Drl-2 | |
7ME4 | Q9V6K3 | Structure of the extracellular WNT-binding module in Drosophila Ror2/Nrk | |
7MDW | 7MDW | CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 | |
7MDW | P0DTC2 | CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 | |
7MDU | Q2N0S6 | BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 | |
7MDU | 7MDU | BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 | |
7MDT | Q2N0S6 | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
7MDT | 7MDT | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
7MD5 | P06213 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
7MD5 | P01308 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
7MBV | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 5 mM calcium and 0.5 mM NDNA | |
7MBU | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (high calcium occupancy in the transmembrane domain) | |
7MBT | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (low calcium occupancy in the transmembrane domain) | |
7MBS | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 6 uM calcium (open state) | |
7MBR | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 6 uM calcium (apo state) | |
7MBQ | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 5 mM calcium | |
7MBP | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 1 mM EDTA | |
7MBO | P03951 | FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR Milvexian (BMS-986177), IUPAC NAME:(6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6- oxopyrimidin-1(6H)-yl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-15,11- (metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one | |
7M8L | A0A1C4HDV6 | EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs | |
7M8L | A0A0E3XK95 | EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs | |
7M8L | 7M8L | EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs | |
7M8K | P0DTC2 | Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up) | |
7M7W | 7M7W | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape | |
7M7W | P0DTC2 | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024